Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucarpidase for delayed MTX clearance or overdose
NCT00219791Phase 2Completed
- Sponsor
- Bio-Technology General
- Start
- Jan 2000
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of glucarpidase in Methotrexate toxicity, sponsored by Bio-Technology General. Started Jan 2000; status: completed.
02
Drugs
glucarpidase
03
Conditions
Methotrexate toxicity
Beyond the preview
Go deeper on NCT00219791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219791.